John B.A.G. Haanen

Researcher Next ID · RN-003144

Researcher · Medicine

Leiden, Netherlands

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Cancer Immunotherapy and Biomarkers

CAR-T cell therapy research

Immunotherapy and Immune Responses

Melanoma and MAPK Pathways

Cutaneous Melanoma Detection and Management

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1910836
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709684
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1103782
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa1003466

No projects listed.